Low Body Mass Index at Treatment Initiation and Rifampicin-Resistant Tuberculosis Treatment Outcomes: An Individual Participant Data Meta-Analysis.
Jonathon R CampbellEdward D ChanDennis FalzonAnete TrajmanSalmaan KeshavjeeChi C LeungAnn C MillerIgnacio Monedero-RecueroDenise S RodriguesHaesook SeoParvaneh BaghaeiZarir UdwadiaPiret ViikleppMayara BastosDick MenziesPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Low body-mass-index at treatment initiation for rifampicin-resistant tuberculosis is associated with increased odds of unfavorable treatment outcome, particularly mortality.
Keyphrases
- body mass index
- mycobacterium tuberculosis
- systematic review
- pulmonary tuberculosis
- physical activity
- type diabetes
- emergency department
- weight gain
- randomized controlled trial
- electronic health record
- cardiovascular disease
- cardiovascular events
- risk factors
- big data
- meta analyses
- weight loss
- hiv infected
- adverse drug
- replacement therapy